Cambridge Investment Research Advisors’s Vident US Equity Strategy ETF VUSE Stock Holding History
Bought
Maintained
Sold
Other funds holding VUSE
BTI
VA
FTUS
Cambridge Investment Research Advisors's VUSE Position: Q4 2023 in Review
Cambridge Investment Research Advisors sold out of Vident US Equity Strategy ETF (VUSE) in Q4 2023, closing a stake of 12,105 shares — an estimated $567K sold.
Cambridge Investment Research Advisors first reported a position in VUSE in Q3 2018 and held it in 7 quarters. The position peaked at $611K in Q2 2023. 24 funds tracked by Wall St. Rank hold VUSE as of Q4 2023.
- Cambridge Investment Research Advisors reported no remaining Vident US Equity Strategy ETF position as of Q4 2023 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 12,105 Vident US Equity Strategy ETF shares in Q4 2023, an estimated $567K.
- Cambridge Investment Research Advisors first reported a position in Vident US Equity Strategy ETF in Q3 2018 and held it in 7 quarters.
- Cambridge Investment Research Advisors's Vident US Equity Strategy ETF position peaked at $611K in Q2 2023.
- 24 funds tracked by Wall St. Rank held Vident US Equity Strategy ETF as of Q4 2023.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.